ETF DAILY NEWS

Equities Analysts Set Expectations for TRDA Q2 Earnings

Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) – HC Wainwright issued their Q2 2026 earnings per share estimates for Entrada Therapeutics in a research note issued on Tuesday, May 20th. HC Wainwright analyst R. Selvaraju expects that the company will earn ($1.12) per share for the quarter. HC Wainwright has a “Buy” rating and a […]

May 22, 2025 - 07:48
 0
Equities Analysts Set Expectations for TRDA Q2 Earnings
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) – HC Wainwright issued their Q2 2026 earnings per share estimates for Entrada Therapeutics in a research note issued on Tuesday, May 20th. HC Wainwright analyst R. Selvaraju expects that the company will earn ($1.12) per share for the quarter. HC Wainwright has a “Buy” rating and a […]
Read More

Tags:

Previous Article

TJX Companies (NYSE:TJX) Given New $142.00 Price Target at TD Securities

Next Article

Webster Financial Co. (NYSE:WBS) Receives $62.58 Consensus Target Price from Bro...

Related Posts

Analysts Set Globus Medical, Inc. (NYSE:GMED) Price Target at $94.00

Analysts Set Globus Medical, Inc. (NYSE:GMED) Price Tar...

May 20, 2025  0

Janus Henderson Group PLC Has $2.79 Million Stock Holdings in GitLab Inc. (NASDAQ:GTLB)

Janus Henderson Group PLC Has $2.79 Million Stock Holdi...

May 21, 2025  0

Grail (GRAL) to Release Quarterly Earnings on Tuesday

Grail (GRAL) to Release Quarterly Earnings on Tuesday

May 12, 2025  0